BAUDAX BIO, INC. (FORMERLY KNOWN AS RECRO PHARMA, INC.)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	1	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	6	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BGR GOVERNMENT AFFAIRS	—	19

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	16
SENATE	16
Centers For Medicare and Medicaid Services (CMS)	6

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	18

BAUDAX BIO, INC. (FORMERLY KNOWN AS RECRO PHARMA, INC.) — Lobbying Disclosure | Poliscope